The novel approach of tirzepatide peptide represents a exciting development in the handling of type 2 diabetes. Unlike existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide820550.ka-blogs.com/95552565/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment